NCT05479552Active, not recruiting
A Diagnostic Test for Dementia With Lewy Bodies
Source: ClinicalTrials.gov · Last updated 15 Jan 2025
Brief summary (registry, in English)
The Syn-D Study will be evaluating α-synuclein in patients with suspected MCI-AD and MCI-DLB. Using a simple diagnostic test will improve clinical accuracy in diagnosing, earlier diagnosis, and distinguish between neurodegenerative diseases.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 80 (estimated)
- First submitted
- 22 Jul 2022
- Start date
- Aug 2022
- Primary completion date
- Sept 2025
- Lead sponsor
- CND Life Sciences
- Diseases
- Lewy body dementia, Alzheimer disease
- NCT number
- NCT05479552
What you commit to
- Study type: Observational
- Planned participants: 80
- From Aug 2022 to the primary completion date, Sept 2025
- 12 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Clinical evidence of severe peripheral vascular disease (Fazekas score of ≥ 3, or a large vessel stroke of ≥ 2 cm, history of ulceration, poor wound healing, vascular claudication)
- Clinically active coronary artery or cerebrovascular disease
- History of allergic reaction to local anesthesia (for biopsy collection)
- Significantly impaired wound healing or history of scarring or keloid formation
Other
- Current smoker or alcoholism
- Use of anticoagulants (aspirin or Plavix alone is allowed)
Who the study is looking for
- Men and women 50 to 85 years of age
- Clinical diagnosis of mild cognitive impairment, and a presumed etiology of DLB or AD at enrollment
Age in the registry: 50 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (12)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Michigan Coordinator of this site? Confirm its status | Ann Arbor | United States | Unknown status |
| University of Miami Coordinator of this site? Confirm its status | Boca Raton | United States | Unknown status |
| Mass General Hospital Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
| Beth Israel Deaconess Medical Center Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
| CenExel RMCR Coordinator of this site? Confirm its status | Englewood | United States | Unknown status |
| University of California San Diego Coordinator of this site? Confirm its status | La Jolla | United States | Unknown status |
| Vanderbilt University Medical Center Coordinator of this site? Confirm its status | Nashville | United States | Unknown status |
| Ochsner Research Coordinator of this site? Confirm its status | New Orleans | United States | Unknown status |
| Headlands Research Coordinator of this site? Confirm its status | Plymouth | United States | Unknown status |
| University of Utah Coordinator of this site? Confirm its status | Salt Lake City | United States | Unknown status |
| CND Life Sciences Coordinator of this site? Confirm its status | Scottsdale | United States | Unknown status |
| Neurology One Coordinator of this site? Confirm its status | Winter Park | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.